Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies

With the widespread use of coronavirus disease 2019 (COVID-19) vaccines, a rapid and reliable method to detect SARS-CoV-2 neutralizing antibodies (NAbs) is extremely important for monitoring vaccine effectiveness and immunity in the population. The purpose of this study was to evaluate the performan...

Descripción completa

Detalles Bibliográficos
Autores principales: Pieri, Massimo, Nicolai, Eleonora, Nuccetelli, Marzia, Sarubbi, Serena, Tomassetti, Flaminia, Pelagalli, Martina, Minieri, Marilena, Terrinoni, Alessandro, Bernardini, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977564/
https://www.ncbi.nlm.nih.gov/pubmed/35377034
http://dx.doi.org/10.1007/s00705-022-05422-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977564/
https://www.ncbi.nlm.nih.gov/pubmed/35377034
http://dx.doi.org/10.1007/s00705-022-05422-w

Ejemplares similares